MYLAN 9 4 Pill: purple, oval, 13mm
The pill with imprint MYLAN 9 4 (Purple, Oval, 13mm) has been identified as Carbidopa and Levodopa Extended Release 50 mg / 200 mg and is used for Parkinson's Disease, Neuroleptic Malignant Syndrome, and GTP-CH Deficiency. It belongs to the drug class dopaminergic antiparkinsonism agents and is not a controlled substance.
Images for MYLAN 9 4
Carbidopa and Levodopa Extended Release
- Imprint
- MYLAN 9 4
- Strength
- 50 mg / 200 mg
- Color
- Purple
- Size
- 13.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
FD&C Blue No. 2,
FD&C Red No. 40,
hydroxypropyl cellulose,
hypromelloses,
magnesium stearate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-0094 | Mylan Pharmaceuticals Inc. |
| 51079-0923 | UDL Laboratories Inc. |
| 67544-0672 | Prepak Systems Inc. (repackager) |
Related images for "MYLAN 9 4"
More about carbidopa / levodopa
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (101)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: dopaminergic antiparkinsonism agents
Patient resources
Other brands
Sinemet, Rytary, Crexont, Sinemet CR, ... +3 more
Professional resources
- Levodopa/Carbidopa monograph
- Carbidopa and Levodopa (FDA)
- Carbidopa and Levodopa ODT (FDA)
- Carbidopa and Levodopa Tablets (FDA)
Other brands
Sinemet, Rytary, Crexont, Sinemet CR, ... +3 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.